Xiaoshi Zhang

机构：Sun Yat-sen University, Jilin Province Tumor Hospital, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China · ORCID：0000-0002-2306-8011

发表论文 10 篇 · 总被引 40 次 · h-index 3

代表论文

• MiR-374b-5p inhibits KDM5B-induced epithelial-mesenchymal transition in pancreatic cancer. (2021 · PubMed · 被引 13)
• Perioperative tislelizumab plus chemotherapy for locally advanced gastroesophageal junction adenocarcinoma (NEOSUMMIT-03): a prospective, nonrandomized, open-label, phase 2 trial (2025 · Signal Transduction and Targeted Therapy · 被引 12)
• Surgical treatment improves overall survival of hepatocellular carcinoma with extrahepatic metastases after conversion therapy: a multicenter retrospective study (2024 · Scientific Reports · 被引 8)
• Efficacy of PD-1 Inhibitors for Colorectal Cancer and Polyps in Lynch Syndrome Patients (2023 · SSRN Electronic Journal · 被引 2)
• The ratio of preoperative alpha-fetoprotein level to total tumor volume as a prognostic factor of hepatocellular carcinoma after liver transplantation (2021 · Medicine · 被引 2)
• Perioperative PD-1 antibody tislelizumab plus chemotherapy for locally advanced gastro-oesophageal junction cancer: A prospective, nonrandomized, open-label, phase II trial. (2024 · Journal of Clinical Oncology · 被引 1)